Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis

Clinical effect of treatment with lipo-prostaglandin E1 on the patients with chronic glomerulonephritis

OBJECTIVE: To investigate potential mechanism underlying lipo-prostaglandin E1 (PGE1) in treatment of patients with chronic glomerulonephritis

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 16(2004), 5 vom: 06. Mai, Seite 292-4
1. Verfasser: Zhong, Wei-qiang (VerfasserIn)
Weitere Verfasser: Liu, Guan-xian, Yang, Yong-ming, Cai, Xun, Huang, Zhong-liang
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2004
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Clinical Trial English Abstract Journal Article Interleukin-1 Tumor Necrosis Factor-alpha Vasodilator Agents Creatinine AYI8EX34EU Alprostadil F5TD010360